Germany recognises Bharat Biotech's Covaxin for travel from June 1
India | May 26, 2022 12:07 ISTThe DCGI in April also granted an emergency use authorisation (EUA) to Covaxin for the age group of 6-12 years.
The DCGI in April also granted an emergency use authorisation (EUA) to Covaxin for the age group of 6-12 years.
Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
The Central government had rolled out precautionary doses of Covid-19 vaccine for all adults in private hospitals on April 10.
China has always been notorious about revealing the actual data of new Covid cases, deaths to the world. Most of the people in China have been given the 'Made in China' vaccine like Sinopharm but this hasn't been that effective compared to other vaccines.
The Centre announced on Friday that the precautionary dose of Covid vaccines will be available to everyone aged above 18 years at the private vaccination centers from April 10.
Serum Institute of India's Covid-19 vaccine Covishield was earlier priced at Rs. 600. Bharat Biotech's Covaxin was priced at Rs 1200.
Recently, in a statement on WHO's suspension of Covaxin, Bharat Biotech said, "For the millions who have received Covaxin, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine."
Earlier on Sunday, Bharat Biotech had said it had nothing else to add to an earlier statement where it said it is working on further improvements and upgrades to ensure that the production of Covaxin continues to meet ever increasing global regulatory requirements.
The vaccine manufacturer has further said that the company is slowing down the production of Covaxin for facility optimization.
The inoculation of children in the age group of 12 to 14 years against COVID-19 started on Wednesday with Corbevax vaccine.
The decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 - although that was before the omicron variant emerged. Side effects were mild, including fever and fatigue.
Covaxin has already been granted Emergency Use Listing (EUL) in 13 countries.
mRNA vaccines belong to the category of nucleic acid vaccines, which use genetic material from disease-causing virus or pathogen to trigger an immune response against it within the body.
India's COVID-19 vaccination coverage has crossed 156 crore with more than 57 lakh vaccine doses administered on Saturday, the Union health ministry said.
In view of continuous spike in Coronavirus cases in Uttar Pradesh, the state government has started a campaign 'My village, my locality is 100% vaccinated'. Under this, health workers are going door-to-door to check on vaccination (Covid-19 Vaccine). Village heads, NGOs are also contributing in this campaign. INDIA TV's special show 'Ye Public Hai Sab Jaanti Hai' reached Deoria and interacted with doctors, CMOs, health workers as well as people regarding this campaign.
According to reports, Bharat Biotech has proposed that its nasal vaccine can be used as booster dose for those who have already been inoculated with Covaxin or Covishield vaccines against coronavirus.
There are many who are confused if they should get vaccinated if the woman is pregnant or a couple is planning to conceive. There are many questions about the COVID-19 vaccine and fertility, here's what medical experts have to say.
Eight Omicron cases have so far been reported in Uttar Pradesh and of the patients, three have recovered and the others are in home isolation, the chief minister said.
The registration for all potential beneficiaries on the Co-WIN portal had begun from January 1, 2022. They can also avail walk-in registration at the vaccination centres from today.
"It's a hat-trick! It's now 3rd vaccine developed in India!", Health Minister Mandaviya said.
Top News
Latest News
